Latest Articles

Michael Kinch confronts a recent controversy in the field of immunology, where researchers failed to seek permission or guidance from the NIAID before engineering mutant forms of SARS-CoV-2.

Featuring expert insights, this article will reflect on recent progress in the multiomics research space, exploring workflow developments, technologies and applications.

In this roundup, we look at recent developments in diagnostics for genetic diseases and a range of cancers that could enable a more personalized approach for patients.

This article will discuss how synthetic biology can be exploited to explore mechanisms of human disease, as well as develop treatments, highlighting key examples.

As the year ends, it’s time to reflect on the stories that you enjoyed the most. Here’s our roundup of this year’s most popular headlines, including new findings on how we humans age, the impact of diet on the microbiome and a revelation on the cause of multiple sclerosis (MS).

From tweets to toots – the online community #SciTwitter is considering a move from Twitter to an alternative online platform. In this article, we explore how Twitter has supported science communication and outreach over recent years, the motivations for migration and ask: where are you heading, #SciTwitter?

Per- and polyfluoroalkyl substances (PFAS) have penetrated every corner of the globe. What do we know about them, why are they such a problem and do they really last “forever”? Science writer Kerry Taylor-Smith explores.

Technology Networks recently had the pleasure of speaking with Dr. Sam Barichievy, director in cell engineering at the biopharmaceutical company AstraZeneca. In this conversation, Dr. Barichievy shares her perspectives on what equality, diversity and inclusion entails, and how fostering inclusive environments can enable us to do better science.

Dr. Jenna Macciochi is a lecturer in immunology at the University of Sussex, where her research centers on understanding the role that nutrition and lifestyle play in human immunity.

Recently, an expose article was published revealing a potential fabrication of data by prominent investigators of Alzheimer’s disease. In this op-ed piece, Michael Kinch explores the catastrophic impact of scientific fraud.